Lindbrook Capital, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Lindbrook Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$144.95 - $152.29 $17,104 - $17,970	118 Added 31.64%	491 $74,000
Q2 2022 Aug 01, 2022	SELL	$83.14 - $145.99 $19,870 - $34,891	-239 Reduced 39.05%	373 $54,000
Q1 2022 Apr 21, 2022	SELL	$110.08 - $142.92 $22,676 - $29,441	-206 Reduced 25.18%	612 $73,000
Q4 2021 Jan 18, 2022	BUY	$99.73 - $148.48 $81,579 - $121,456	818 New	818 $113,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.